2023-509665-20-00RecruitingPhase 1
ADP-TILIL7
Source: EU CTIS (euclinicaltrials.eu) · Last updated 25 Jun 2024 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- First submitted
- 29 Nov 2023
- Start date
- 15 Aug 2024
- Lead sponsor
- Herlev Hospital
- Diseases
- Melanoma
- EU CT number
- 2023-509665-20-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 10
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with locally advanced or metastatic melanoma. The record gives no other details.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- Locally advanced or metastatic melanoma
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Herlev Hospital | Herlev | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.